Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
True Biotech is a specialized biotechnology company based in Taiwan that focuses on the development, manufacturing, and global distribution of rapid in vitro diagnostic (IVD) solutions. Utilizing its core expertise in lateral flow immunoassay technology, the company provides high-sensitivity diagnostic kits for a wide range of clinical applications, including infectious diseases, gastrointestinal health, and cardiac markers. Its product portfolio features prominent tests such as the H. pylori Antigen Rapid Test, Fecal Occult Blood (FOB) tests for colorectal cancer screening, and Cardiac Troponin I tests for the early detection of myocardial infarction. True Biotech operates out of ISO 13485-certified facilities and serves clinical laboratories, hospitals, and point-of-care providers worldwide. The company is committed to enhancing healthcare outcomes through the provision of fast, accurate, and accessible diagnostic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on True Biotech.